Clinical Trial Update: Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing margetuximab plus chemotherapy to trastuzumab plus chemotherapy in HER2-positive metastatic breast cancer; the study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Margetuximab (margetuximab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: MacroGenics | Conditions: HER-2 Positive Breast Cancer, Metastatic Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2022-11-23